Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-034708
Filing Date
2015-06-01
Accepted
2015-06-01 12:35:13
Documents
1
Period of Report
2015-05-29

Document Format Files

Seq Description Document Type Size
1 form474664_20150601123355-.html 4  
1 form474664_20150601123355-.xml 4 3348
  Complete submission text file 0001144204-15-034708.txt   4798
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 425 METRO PLACE N., SUITE 300 DUBLIN OH 43017
Business Address
Troup Gordon A (Reporting) CIK: 0001441122 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35076 | Film No.: 15902271